Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

Recruiting now · Phase 2

Conditions studied: Bronchopulmonary Dysplasia

In brief

Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.

Key facts

Study ID
NCT06270199
Run by
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
People needed
75
Starts
2024-01-11
Expected to finish
2026-12-01
Last updated by the study team
2025-03-17

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.